Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAptitude Regulatory News (APTD)

Share Price Information for Aptitude (APTD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 380.00
Bid: 374.00
Ask: 384.00
Change: 10.00 (2.70%)
Spread: 10.00 (2.674%)
Open: 382.00
High: 382.00
Low: 380.00
Prev. Close: 370.00
APTD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

7 Jul 2009 07:00

RNS Number : 2015V
Microgen PLC
07 July 2009
 



microgen

www.microgen.com

 7 July 2009

M icrogen plc

Trading Update

Microgen plc ('Microgen' or 'the Group'provides an update on trading ahead of the Group's Interim Results, for the six months ended 30 June 2009, which are anticipated to be released in late July. 

During the first half of 2009, Microgen Aptitude Solutions Division ("MASD") has seen considerable success. In addition to the multi-million pound contract reported in the April Interim Management Statementthe division is also now engaged on three significant new customer projects :

Major UK Bank : MASD has recently signed a contract for Microgen Accounting Hub and Microgen Aptitude. This project is anticipated to produce revenue in excess of £1 million in the coming year.

US Manufacturer : In parallel with final contract negotiations, MASD is commencing the initial design phase of a project for Microgen Aptitude which is also anticipated to produce revenue in excess of £1 million in the coming year.

Major US Financial Institution : MASD is currently undertaking a significant customer-funded proof-of-concept which may or may not lead to a major contract for Microgen Aptitude and/or Microgen Accounting Hub.

As a result of these projects and additional prospects, the Board anticipates MASD delivering a strong second half of the year. The operating loss for MASD in the first-half has significantly reduced compared to the prior year. Microgen expenses all development costs as incurred and has no R&D capitalisation on its balance sheet. This results in a high correlation between operating income and cash flow for the Group as a whole and, as the revenue increases within MASD, profitability of this division should scale accordingly.

As anticipated, the Group's Billing Services Division and Financial Systems Division have reflected the economic climate but are trading in line with the Board's expectations. These divisions have high recurring revenue and hence remain profitable, high margin businesses with strong cash flow.

Cash at 30 June 2009 was £15.2 million, compared to £14.7 million at 31 December 2008, after repayment of £1.3 million of the loan associated with the freehold property and payment of the final dividend of £1.2 million.

Overall, despite the continuing difficult market environment, the first half of 2009 is anticipated to be in line with the Board's expectations, but, as a result of the strong MASD performance, and subject to contracts being finalised for the two projects noted aboveearnings for the year are anticipated to be ahead of current market expectations.

Contacts

Martyn Ratcliffe, Chairman

01252-772300

David Sherriff, Chief Operating Officer

Philip Wood, Group Finance Director

Giles Sanderson, Financial Dynamics

Haya Chelhot, Financial Dynamics

020-7831-3113

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBSGDRXXGGGCL
Date   Source Headline
7th Sep 202310:15 amRNSGrant of Awards under Performance Share Plan
23rd Aug 20231:21 pmRNSHolding(s) in Company
23rd Aug 20231:15 pmRNSHolding(s) in Company
28th Jul 202312:18 pmRNSHolding(s) in Company
28th Jul 20237:00 amRNSHolding(s) in Company
27th Jul 20231:52 pmRNSHolding(s) in Company
26th Jul 20237:00 amRNSInterim Results
24th Jul 20235:22 pmRNSHolding(s) in Company
20th Jul 20237:00 amRNSHolding(s) in Company
19th Jul 20237:00 amRNSDirector Retirement
13th Jul 20237:00 amRNSTrading Update and Directorate Changes
23rd Jun 20234:43 pmRNSHolding(s) in Company
16th Jun 20234:22 pmRNSHolding(s) in Company
25th May 20235:22 pmRNSDirector/PDMR Shareholding
24th May 202311:01 amRNSHolding(s) in Company
23rd May 20236:10 pmRNSDirector/PDMR Shareholding
23rd May 20233:27 pmRNSHolding(s) in Company
17th May 202311:24 amRNSResult of AGM
17th May 20237:00 amRNSAGM Statement and Appointment of CFO
2nd May 202311:44 amRNSHolding(s) in Company
24th Apr 20235:13 pmRNSExercise of awards under 2020 Deferred Bonus Plan
20th Apr 202311:30 amRNSGrant of awards under 2020 Deferred Bonus Plan
17th Apr 202311:49 amRNSHolding(s) in Company
17th Apr 20238:32 amRNSHolding(s) in Company
29th Mar 20234:36 pmRNSDirector/PDMR Shareholding
29th Mar 20234:35 pmRNSPrice Monitoring Extension
29th Mar 202311:27 amRNSBLOCK LISTING SIX MONTHLY RETURN
21st Mar 20237:00 amRNSAudited Results for Year Ended 31 December 2022
13th Feb 20235:20 pmRNSHolding(s) in Company
1st Feb 20234:40 pmRNSSecond Price Monitoring Extn
1st Feb 20234:35 pmRNSPrice Monitoring Extension
26th Jan 20237:00 amRNSHolding(s) in Company
24th Jan 20237:00 amRNSFull Year Trading Update and Directorate Change
12th Jan 20239:51 amRNSNew Directorship Notification
24th Nov 20227:00 amRNSGrant of awards under Performance Share Plan
8th Nov 20227:00 amRNSGrant of awards
21st Oct 20224:41 pmRNSSecond Price Monitoring Extn
21st Oct 20224:36 pmRNSPrice Monitoring Extension
28th Sep 20227:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
28th Jul 20227:00 amRNSInterim Results
18th Jul 20227:00 amRNSNotice of Results
31st May 202211:40 amRNSTotal Voting Rights
26th May 20228:56 amRNSHolding(s) in Company
17th May 20221:57 pmRNSDirector/PDMR Shareholding and Total Voting Rights
5th May 20222:10 pmRNSDirector Shareholding
29th Apr 202210:56 amRNSTotal Voting Rights
28th Apr 202212:24 pmRNSResult of AGM and Directorate Change
28th Apr 20227:00 amRNSAGM Statement
12th Apr 202211:50 amRNSBlock Listing Application
11th Apr 20222:30 pmRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.